Protalix BioTherapeutics (PLX) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.93% |
| Dec 31, 2025 | -8.13% |
| Sep 30, 2025 | -7.15% |
| Jun 30, 2025 | 25.83% |
| Mar 31, 2025 | 28.35% |
| Dec 31, 2024 | 66.18% |
| Sep 30, 2024 | 33.11% |
| Jun 30, 2024 | 6.55% |
| Mar 31, 2024 | -46.77% |
| Dec 31, 2023 | -100.90% |
| Sep 30, 2023 | -96.89% |
| Jun 30, 2023 | -68.63% |
| Mar 31, 2023 | -0.36% |
| Dec 31, 2022 | 43.11% |
| Sep 30, 2022 | 57.23% |
| Jun 30, 2022 | 62.86% |
| Mar 31, 2022 | 53.26% |
| Dec 31, 2021 | -88.19% |
| Sep 30, 2021 | -17.84% |
| Jun 30, 2021 | -119.89% |
| Mar 31, 2021 | -92.04% |
| Dec 31, 2020 | -16.43% |
| Sep 30, 2020 | -92.58% |
| Jun 30, 2020 | -39.42% |
| Mar 31, 2020 | -20.79% |
| Dec 31, 2019 | 52.94% |
| Sep 30, 2019 | 48.79% |
| Jun 30, 2019 | 11.41% |
| Mar 31, 2019 | 26.52% |
| Dec 31, 2018 | 26.10% |
| Sep 30, 2018 | -25.05% |
| Jun 30, 2018 | 17.97% |
| Mar 31, 2018 | 13.95% |
| Dec 31, 2017 | 19.15% |
| Sep 30, 2017 | 34.76% |
| Jun 30, 2017 | 36.78% |
| Mar 31, 2017 | 27.98% |
| Dec 31, 2016 | 17.14% |
| Sep 30, 2016 | -49.85% |
| Jun 30, 2016 | -26.34% |
| Mar 31, 2016 | -39.02% |
| Dec 31, 2015 | -39.45% |
| Mar 31, 2015 | 38.27% |
| Dec 31, 2014 | 36.61% |
| Mar 31, 2014 | -85.55% |
| Dec 31, 2013 | -66.04% |
| Sep 30, 2013 | -82.01% |
| Jun 30, 2013 | 44.12% |
| Mar 31, 2013 | 8.19% |
| Dec 31, 2012 | -92.72% |
| Sep 30, 2012 | -45.28% |
| Jun 30, 2012 | -34.56% |
| Mar 31, 2012 | 9.20% |
| Dec 31, 2011 | 24.79% |
| Sep 30, 2011 | 22.15% |
| Jun 30, 2011 | 19.84% |